content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <headerData>
  <submissionType>144</submissionType>
  <filerInfo>
  <filer>
  <filerCredentials>
  <cik>0001688313</cik>
  <ccc>XXXXXXXX</ccc>
  </filerCredentials>
  </filer>
  <liveTestFlag>LIVE</liveTestFlag>
  </filerInfo>
  </headerData>
  <formData>
  <issuerInfo>
  <issuerCik>0001484565</issuerCik>
  <issuerName>Soleno Therapeutics, Inc.</issuerName>
  <secFileNumber>001-36593</secFileNumber>
  <issuerAddress>
  <street1 xmlns="http://www.sec.gov/edgar/common">203 Redwood Shores Parkway</street1>
  <street2 xmlns="http://www.sec.gov/edgar/common">Suite 500</street2>
  <city xmlns="http://www.sec.gov/edgar/common">Redwood City</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">CA</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">94065</zipCode>
  </issuerAddress>
  <issuerContactPhone>650-213-8444</issuerContactPhone>
  <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Abingworth Bioventures VII LP</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
  <relationshipsToIssuer>
  <relationshipToIssuer>Rule 144 Affiliate</relationshipToIssuer>
  </relationshipsToIssuer>
  </issuerInfo>
  <securitiesInformation>
  <securitiesClassTitle>Common Stock</securitiesClassTitle>
  <brokerOrMarketmakerDetails>
  <name>BTIG, LLC</name>
  <address>
  <street1 xmlns="http://www.sec.gov/edgar/common">350 Bush Street, 9th Floor</street1>
  <city xmlns="http://www.sec.gov/edgar/common">San Francisco,</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">CA</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">94104</zipCode>
  </address>
  </brokerOrMarketmakerDetails>
  <noOfUnitsSold>949336</noOfUnitsSold>
  <aggregateMarketValue>51416038</aggregateMarketValue>
  <noOfUnitsOutstanding>38871594</noOfUnitsOutstanding>
  <approxSaleDate>10/21/2024</approxSaleDate>
  <securitiesExchangeName>NASDAQ</securitiesExchangeName>
  </securitiesInformation>
  <securitiesToBeSold>
  <securitiesClassTitle>Common Stock</securitiesClassTitle>
  <acquiredDate>10/12/2023</acquiredDate>
  <natureOfAcquisitionTransaction>Acquired in multiple transactions directly from the Issuer and upon exercise of warrants.</natureOfAcquisitionTransaction>
  <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
  <isGiftTransaction>N</isGiftTransaction>
  <amountOfSecuritiesAcquired>949336</amountOfSecuritiesAcquired>
  <paymentDate>10/12/2023</paymentDate>
  <natureOfPayment>Cash consideration upon purchase or net exercise</natureOfPayment>
  </securitiesToBeSold>
  <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
  <securitiesSoldInPast3Months>
  <sellerDetails>
  <name>Abingworth Bioventures VII LP</name>
  <address>
  <street1 xmlns="http://www.sec.gov/edgar/common">38 Jermyn Street</street1>
  <city xmlns="http://www.sec.gov/edgar/common">London</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">X0</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">SW1Y 6DN</zipCode>
  </address>
  </sellerDetails>
  <securitiesClassTitle>Common Stock</securitiesClassTitle>
  <saleDate>10/07/2024</saleDate>
  <amountOfSecuritiesSold>22096</amountOfSecuritiesSold>
  <grossProceeds>1076713</grossProceeds>
  </securitiesSoldInPast3Months>
  <securitiesSoldInPast3Months>
  <sellerDetails>
  <name>Abingworth Bioventures VII LP</name>
  <address>
  <street1 xmlns="http://www.sec.gov/edgar/common">38 Jermyn Street</street1>
  <city xmlns="http://www.sec.gov/edgar/common">London</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">X0</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">SW1Y 6DN</zipCode>
  </address>
  </sellerDetails>
  <securitiesClassTitle>Common Stock</securitiesClassTitle>
  <saleDate>10/08/2024</saleDate>
  <amountOfSecuritiesSold>827801</amountOfSecuritiesSold>
  <grossProceeds>44426341</grossProceeds>
  </securitiesSoldInPast3Months>
  <securitiesSoldInPast3Months>
  <sellerDetails>
  <name>Abingworth Bioventures VII LP</name>
  <address>
  <street1 xmlns="http://www.sec.gov/edgar/common">38 Jermyn Street</street1>
  <city xmlns="http://www.sec.gov/edgar/common">London</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">X0</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">SW1Y 6DN</zipCode>
  </address>
  </sellerDetails>
  <securitiesClassTitle>Common Stock</securitiesClassTitle>
  <saleDate>10/09/2024</saleDate>
  <amountOfSecuritiesSold>255963</amountOfSecuritiesSold>
  <grossProceeds>13067090</grossProceeds>
  </securitiesSoldInPast3Months>
  <securitiesSoldInPast3Months>
  <sellerDetails>
  <name>Abingworth Bioventures VII LP</name>
  <address>
  <street1 xmlns="http://www.sec.gov/edgar/common">38 Jermyn Street</street1>
  <city xmlns="http://www.sec.gov/edgar/common">London</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">X0</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">SW1Y 6DN</zipCode>
  </address>
  </sellerDetails>
  <securitiesClassTitle>Common Stock</securitiesClassTitle>
  <saleDate>10/10/2024</saleDate>
  <amountOfSecuritiesSold>182489</amountOfSecuritiesSold>
  <grossProceeds>9240275</grossProceeds>
  </securitiesSoldInPast3Months>
  <securitiesSoldInPast3Months>
  <sellerDetails>
  <name>Abingworth Bioventures VII LP</name>
  <address>
  <street1 xmlns="http://www.sec.gov/edgar/common">38 Jermyn Street</street1>
  <city xmlns="http://www.sec.gov/edgar/common">London</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">X0</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">SW1Y 6DN</zipCode>
  </address>
  </sellerDetails>
  <securitiesClassTitle>Common Stock</securitiesClassTitle>
  <saleDate>10/11/2024</saleDate>
  <amountOfSecuritiesSold>344527</amountOfSecuritiesSold>
  <grossProceeds>18636499</grossProceeds>
  </securitiesSoldInPast3Months>
  <securitiesSoldInPast3Months>
  <sellerDetails>
  <name>Abingworth Bioventures VII LP</name>
  <address>
  <street1 xmlns="http://www.sec.gov/edgar/common">38 Jermyn Street</street1>
  <city xmlns="http://www.sec.gov/edgar/common">London</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">X0</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">SW1Y 6DN</zipCode>
  </address>
  </sellerDetails>
  <securitiesClassTitle>Common Stock</securitiesClassTitle>
  <saleDate>10/14/2024</saleDate>
  <amountOfSecuritiesSold>107810</amountOfSecuritiesSold>
  <grossProceeds>5869500</grossProceeds>
  </securitiesSoldInPast3Months>
  <securitiesSoldInPast3Months>
  <sellerDetails>
  <name>Abingworth Bioventures VII LP</name>
  <address>
  <street1 xmlns="http://www.sec.gov/edgar/common">38 Jermyn Street</street1>
  <city xmlns="http://www.sec.gov/edgar/common">London</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">X0</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">SW1Y 6DN</zipCode>
  </address>
  </sellerDetails>
  <securitiesClassTitle>Common Stock</securitiesClassTitle>
  <saleDate>10/15/2024</saleDate>
  <amountOfSecuritiesSold>121159</amountOfSecuritiesSold>
  <grossProceeds>6567096</grossProceeds>
  </securitiesSoldInPast3Months>
  <securitiesSoldInPast3Months>
  <sellerDetails>
  <name>Abingworth Bioventures VII LP</name>
  <address>
  <street1 xmlns="http://www.sec.gov/edgar/common">38 Jermyn Street</street1>
  <city xmlns="http://www.sec.gov/edgar/common">London</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">X0</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">SW1Y 6DN</zipCode>
  </address>
  </sellerDetails>
  <securitiesClassTitle>Common Stock</securitiesClassTitle>
  <saleDate>10/16/2024</saleDate>
  <amountOfSecuritiesSold>113899</amountOfSecuritiesSold>
  <grossProceeds>6214079</grossProceeds>
  </securitiesSoldInPast3Months>
  <securitiesSoldInPast3Months>
  <sellerDetails>
  <name>Abingworth Bioventures VII LP</name>
  <address>
  <street1 xmlns="http://www.sec.gov/edgar/common">38 Jermyn Street</street1>
  <city xmlns="http://www.sec.gov/edgar/common">London</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">X0</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">SW1Y 6DN</zipCode>
  </address>
  </sellerDetails>
  <securitiesClassTitle>Common Stock</securitiesClassTitle>
  <saleDate>10/17/2024</saleDate>
  <amountOfSecuritiesSold>156179</amountOfSecuritiesSold>
  <grossProceeds>8349829</grossProceeds>
  </securitiesSoldInPast3Months>
  <securitiesSoldInPast3Months>
  <sellerDetails>
  <name>Abingworth Bioventures VII LP</name>
  <address>
  <street1 xmlns="http://www.sec.gov/edgar/common">38 Jermyn Street</street1>
  <city xmlns="http://www.sec.gov/edgar/common">London</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">X0</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">SW1Y 6DN</zipCode>
  </address>
  </sellerDetails>
  <securitiesClassTitle>Common Stock</securitiesClassTitle>
  <saleDate>10/18/2024</saleDate>
  <amountOfSecuritiesSold>113450</amountOfSecuritiesSold>
  <grossProceeds>6131450</grossProceeds>
  </securitiesSoldInPast3Months>
  <noticeSignature>
  <noticeDate>10/21/2024</noticeDate>
  <planAdoptionDates>
  <planAdoptionDate>09/06/2024</planAdoptionDate>
  </planAdoptionDates>
  <signature>Abingworth Bioventures VII LP, acting by its Manager, Abingworth LLP, /s/ John Heard, General Counsel</signature>
  </noticeSignature>
  </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 9276}]
text: 144
  0001688313
  XXXXXXXX
  LIVE
  0001484565
  Soleno Therapeutics, Inc.
  001-36593
  203 Redwood Shores Parkway
  Suite 500
  Redwood City
  CA
  94065
  650-213-8444
  Abingworth Bioventures VII LP
  Rule 144 Affiliate
  Common Stock
  BTIG, LLC
  350 Bush Street, 9th Floor
  San Francisco,
  CA
  94104
  949336
  51416038
  38871594
  10/21/2024
  NASDAQ
  Common Stock
  10/12/2023
  Acquired in multiple transactions directly from the Issuer and upon exercise of warrants.
  Issuer
  N
  949336
  10/12/2023
  Cash consideration upon purchase or net exercise
  N
  Abingworth Bioventures VII LP
  38 Jermyn Street
  London
  X0
  SW1Y 6DN
  Common Stock
  10/07/2024
  22096
  1076713
  Abingworth Bioventures VII LP
  38 Jermyn Street
  London
  X0
  SW1Y 6DN
  Common Stock
  10/08/2024
  827801
  44426341
  Abingworth Bioventures VII LP
  38 Jermyn Street
  London
  X0
  SW1Y 6DN
  Common Stock
  10/09/2024
  255963
  13067090
  Abingworth Bioventures VII LP
  38 Jermyn Street
  London
  X0
  SW1Y 6DN
  Common Stock
  10/10/2024
  182489
  9240275
  Abingworth Bioventures VII LP
  38 Jermyn Street
  London
  X0
  SW1Y 6DN
  Common Stock
  10/11/2024
  344527
  18636499
  Abingworth Bioventures VII LP
  38 Jermyn Street
  London
  X0
  SW1Y 6DN
  Common Stock
  10/14/2024
  107810
  5869500
  Abingworth Bioventures VII LP
  38 Jermyn Street
  London
  X0
  SW1Y 6DN
  Common Stock
  10/15/2024
  121159
  6567096
  Abingworth Bioventures VII LP
  38 Jermyn Street
  London
  X0
  SW1Y 6DN
  Common Stock
  10/16/2024
  113899
  6214079
  Abingworth Bioventures VII LP
  38 Jermyn Street
  London
  X0
  SW1Y 6DN
  Common Stock
  10/17/2024
  156179
  8349829
  Abingworth Bioventures VII LP
  38 Jermyn Street
  London
  X0
  SW1Y 6DN
  Common Stock
  10/18/2024
  113450
  6131450
  10/21/2024
  09/06/2024
  Abingworth Bioventures VII LP, acting by its Manager, Abingworth LLP, /s/ John Heard, General Counsel